nlnk-20210930

000112623412/312021Q3false--12-31http://fasb.org/us-gaap/2021-01-31#LicenseAndServiceMember.111100011262342021-01-012021-09-30xbrli:shares00011262342021-11-01iso4217:USD00011262342021-09-3000011262342020-12-31iso4217:USDxbrli:shares0001126234us-gaap:LicenseAndServiceMembernlnk:MerckSharpeandDohmeCorpMember2021-07-012021-09-300001126234us-gaap:LicenseAndServiceMembernlnk:MerckSharpeandDohmeCorpMember2020-07-012020-09-3000011262342020-01-012020-09-3000011262342021-07-012021-09-3000011262342020-07-012020-09-300001126234us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2019-12-310001126234us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2019-12-310001126234us-gaap:CommonStockMember2019-12-310001126234us-gaap:TreasuryStockMember2019-12-310001126234us-gaap:AdditionalPaidInCapitalMember2019-12-310001126234us-gaap:RetainedEarningsMember2019-12-3100011262342019-12-310001126234us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2020-01-012020-03-310001126234us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2020-01-012020-03-310001126234us-gaap:RetainedEarningsMember2020-01-012020-03-3100011262342020-01-012020-03-310001126234us-gaap:CommonStockMember2020-01-012020-03-310001126234us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-31

SEC Form 10-Q filed by Lumos Pharma, Inc.